Publicación:
Administration and therapeutic drug monitoring of ß-lactams 2 and vancomycin in critical care units in Colombia : The ANTI- 3 BIOCOL study

dc.contributor.advisorDíaz Quijano, Diana Marcela
dc.contributor.authorFuentes Barreiro, Yuly Viviana
dc.contributor.otherBlanco Mejía, Jhosep Andrés
dc.contributor.otherLechtig, Sharon
dc.contributor.otherLiebisch Rey, Hans Nicolás
dc.contributor.otherDíaz Pinilla, Nicolás
dc.contributor.otherVergara Ramírez, Peter
dc.contributor.otherBustos Cruz, Rosa Helena
dc.date.accessioned2022-01-27T14:47:40Z
dc.date.available2022-01-27T14:47:40Z
dc.date.issued2021-08-11
dc.description15 páginases_CO
dc.description.abstractTherapeutic Drug Monitoring (TDM) and continuous infusion strategies are effec- 15 tive interventions in clinical practice, but these practices are little still unknown in Colombia, 16 especially in the critical care setting. This study aims to describe the practices of administra- 17 tion and TDM of time-dependent antibiotics reported by specialists in critical care in Colom- 18 bia and to explore the factors that are related to the use of extended infusion. An online na- 19 tionwide survey was applied to 153 specialists selected randomly. A descriptive, bivariate 20 analysis and a logistic regression model were performed. Of the 88.9% of intensivists referred 21 to TDM availability, 21.57% has access to results access in less than 6 hours. TDM was avail- 22 able mainly for vancomycin. 85.62% of the intensivists had some type of institutional proto- 23 col, however, only 39.22% had a complete and socialized protocol. The odds of preferring 24 extended infusions among those who do not have institutional protocols decrease by 80% 25 compared with those with complete protocols, OR 0.2 (95% CI: 0.06 - 0.61). The most im- 26 portant perceived barriers to performing continuous infusions and TDM are the lack of train- 27 ing and technologies. This pioneering study in Colombia could impact the quality of care and 28 outcomes of critically ill patients on the threat that is antimicrobial resistance.en
dc.description.provenanceSubmitted by contacto intellectum (contactointellectum@unisabana.edu.co) on 2022-01-27T14:47:40Z No. of bitstreams: 3 The ANTIBIOCOL study.pdf: 739417 bytes, checksum: ef7a83deb2b90646e3cd9ee637ac8dc4 (MD5) ANTIBIOCOL Survey. Appendix S1.pdf: 222209 bytes, checksum: 50ad4de2dee1897652314b2c1a8e9cee (MD5) license_rdf: 805 bytes, checksum: 4460e5956bc1d1639be9ae6146a50347 (MD5)en
dc.description.provenanceMade available in DSpace on 2022-01-27T14:47:40Z (GMT). No. of bitstreams: 3 The ANTIBIOCOL study.pdf: 739417 bytes, checksum: ef7a83deb2b90646e3cd9ee637ac8dc4 (MD5) ANTIBIOCOL Survey. Appendix S1.pdf: 222209 bytes, checksum: 50ad4de2dee1897652314b2c1a8e9cee (MD5) license_rdf: 805 bytes, checksum: 4460e5956bc1d1639be9ae6146a50347 (MD5) Previous issue date: 2021-08-11en
dc.formatapplication/pdfes_CO
dc.identifier.local283024
dc.identifier.localTE11429
dc.identifier.urihttps://hdl.handle.net/10818/49519
dc.language.isoenges_CO
dc.publisherUniversidad de La Sabanaes_CO
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.accessRightsrestrictedAccesses_CO
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceUniversidad de La Sabana
dc.sourceIntellectum Repositorio Universidad de La Sabana
dc.subject.armarcFarmacovigilanciaes_CO
dc.subject.armarcCuidados intensivoses_CO
dc.subject.armarcEncuestas de saludes_CO
dc.subject.decsAgentes antiinfecciososes_CO
dc.subject.decsVancomicinaes_CO
dc.titleAdministration and therapeutic drug monitoring of ß-lactams 2 and vancomycin in critical care units in Colombia : The ANTI- 3 BIOCOL studyen
dc.typeTesis/Trabajo de grado – Maestría
dc.type.hasVersionpublishedVersiones_CO
dspace.entity.typePublication
thesis.degree.disciplineFacultad de Medicinaes_CO
thesis.degree.levelMaestría en Epidemiologíaes_CO
thesis.degree.nameMagíster en Epidemiologíaes_CO

Archivos

Bloque original

Mostrando 1 - 2 de 2
Cargando...
Miniatura
Nombre:
The ANTIBIOCOL study.pdf
Tamaño:
722.09 KB
Formato:
Adobe Portable Document Format
Descripción:
Ver documento en PDF
Cargando...
Miniatura
Nombre:
ANTIBIOCOL Survey. Appendix S1.pdf
Tamaño:
217 KB
Formato:
Adobe Portable Document Format
Descripción:
Appendix

Bloque de licencias

Mostrando 1 - 2 de 2
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
498 B
Formato:
Item-specific license agreed upon to submission
Descripción:
Cargando...
Miniatura
Nombre:
Formato de autorizacion de divulgacion RI trabajos de grado V2bk.pdf
Tamaño:
491.85 KB
Formato:
Adobe Portable Document Format
Descripción:
Carta